INTERNATIONAL COVID-19 CLINICAL EVALUATION REGISTRY: HOPE-COVID 19. (Health Outcome Predictive Evaluation for COVID 19) (HOPE COVID 19)

Study type

• Study type:
  Non-interventional study
• Scope of the study:
  Assessment of risk minimisation measure implementation or effectiveness

Non-interventional study

• Non-interventional study design:
  Cross-sectional

Study drug and medical condition

• Medical condition to be studied:
  Viral infection
• Additional medical condition(s):
  COVID-19

Population studied

• Age groups:
  Infants and toddlers (28 days – 23 months)

  Children (2 to < 12 years)

  Adolescents (12 to < 18 years)

  Adults (18 to < 46 years)

  Adults (46 to < 65 years)

  Adults (65 to < 75 years)

  Adults (75 to < 85 years)

  Adults (85 years and over)
• Special population of interest:
  Renal impaired

  Hepatic impaired

  Immunocompromised

  Pregnant women
• Estimated number of subjects:
  2000

Study design details

• Main study objective:
  Revie mortality factors in COVID 19
• Outcomes:
  Mortality, Clinical eventos.
• Data analysis plan:
  Univariate and multivariate analysis. Depending on results probably propensity score assesment.